<< Read Full Article
<< Read Full Article
Cubist Pharma Swings to a Profit
Cubist Pharmaceuticals(CBST) swung to a second-quarter profit from a loss one year ago as sales of its antibiotic Cubicin met reduced Street expectations.
The Lexington, Mass.-based drug maker reiterated 2009 sales guidance for Cubicin in the range of $520 million to $540 million.
Net income for the June quarter totaled $23.8 million, or 40 cents a share, compared to a net loss of $1.3 million or 2 cents a share in the year-ago quarter. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,763.67 | 1,163.93 | 2,389.02 | 36.72 |
Oil *
81.62
|
|
UP
30.00
|
DOWN
2.28
|
DOWN
0.07
|
UP
0.30
|
10 Yr
3.67%
SPDR Gold
110.38
|
|
+0.28%
|
-0.20%
|
+0.00%
|
+0.82%
|
Data delayed 20 minutes |
More From TheStreet
Latest Headlines
Brokerage Partners
Sponsored Links
Connect with TheStreet